You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Philadelphia-Negative ALL

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Lymphoblastic Leukemia, Adult Trial in Caba (Evaluation of survival and toxicities in AYA Ph-negative ALL patients

Recruiting
  • Acute Lymphoblastic Leukemia, Adult
  • Evaluation of survival and toxicities in AYA Ph-negative ALL patients treating in first line depending on risk category.
  • Paraná, Entre Ríos, Argentina
  • +1 more
Dec 29, 2022

Acute Lymphoblastic Leukemia Trial in Suzhou (cladribine, cytarabine,venetoclax)

Recruiting
  • Acute Lymphoblastic Leukemia
  • cladribine, cytarabine,venetoclax
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Dec 22, 2022

Acute Lymphoblastic Leukemia Trial in United States (Calaspargase pegol (S95015))

Recruiting
  • Acute Lymphoblastic Leukemia
  • Calaspargase pegol (S95015)
  • Scottsdale, Arizona
  • +14 more
Dec 13, 2022

Philadelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALL Trial in Spain (blinatumomab)

Terminated
  • Philadelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALL
  • Badalona, Barcelona, Spain
  • +11 more
Jul 26, 2022

B Acute Lymphoblastic Leukemia Trial in Suzhou (Blinatumomab)

Recruiting
  • B Acute Lymphoblastic Leukemia
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University, Jiangsu Ins
Nov 1, 2022

Acute Lymphoblastic Leukemia Trial (GRASPA)

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • (no location specified)
Sep 21, 2021

Philadelphia-Negative ALL, High-Risk Cancer Trial in Israel (Blinatumomab)

Recruiting
  • Philadelphia-Negative ALL
  • High-Risk Cancer
  • Haifa, Israel
  • +3 more
May 6, 2021

B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative Trial in Seattle (procedure, drug, biological)

Not yet recruiting
  • B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
  • Bone Marrow Aspiration and Biopsy
  • +7 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 11, 2022

Epidemiological and Clinical-pathological Factors of

Completed
  • Myeloproliferative Neoplasm
  • +4 more
    • Guayaquil, Guayas, Ecuador
      Sociedad de Lucha Contra el Cáncer
    Apr 25, 2023

    B-cell Acute Lymphoblastic Leukemia Trial in Tampa, Durham, Winston-Salem (Blinatumomab)

    Withdrawn
    • B-cell Acute Lymphoblastic Leukemia
    • Tampa, Florida
    • +2 more
    Feb 14, 2022

    Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Trial in Tianjin (Vincristine, Daunorubicin, Cyclophosphamide)

    Recruiting
    • Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
    • Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Dec 13, 2022

    Carotid Plaque Burden in Philadelphia Negative

    Recruiting
    • Myeloproliferative Neoplasm
      • Sohag, Egypt
        Faculty of Medicine
      Aug 14, 2023

      Acute Undifferentiated Leukemia, B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia Trial

      Completed
      Has Results
      • Acute Undifferentiated Leukemia
      • +13 more
      • Chicago, Illinois
        Cancer and Leukemia Group B
      Apr 5, 2022

      T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail

      Recruiting
      • T-cell Lymphoma
      • +30 more
      • Optional Blood Sample
      • Optional Nail Sample
      • Duarte, California
      • +25 more
      Jul 28, 2023

      Philadelphia-Positive ALL Trial in Suzhou (Olverembatinib)

      Not yet recruiting
      • Philadelphia-Positive ALL
      • Suzhou, Jiangsu, China
        First Affiliated Hospital of Soochow University
      Jul 1, 2023

      Philadelphia Chromosome Negative, Recurrent B Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia Trial in

      Terminated
      Has Results
      • Philadelphia Chromosome Negative
      • +2 more
      • Blinatumomab
      • +11 more
      • Houston, Texas
        M D Anderson Cancer Center
      Nov 3, 2022

      Philadelphia Negative Myeloproliferative Tumors Trial

      Not yet recruiting
      • Philadelphia Negative Myeloproliferative Neoplasms
        • (no location specified)
        Jun 5, 2022

        B Acute Lymphoblastic Leukemia, Ph-Negative ALL, High Risk Acute Lymphoblastic Leukemia Trial (Azacitidine Injection,

        Not yet recruiting
        • B Acute Lymphoblastic Leukemia
        • +2 more
        • Azacitidine Injection
        • +2 more
        • (no location specified)
        Oct 15, 2023

        Acute Lymphoblastic Leukemia (ALL) Trial (Nilotinib)

        No longer available
        • Acute Lymphoblastic Leukemia (ALL)
        • (no location specified)
        Aug 5, 2022

        Esophagogastric Cancer, HER2-Negative Trial in United States (regorafenib, nivolumab, FOLFOX chemo with oxaliplatin)

        Active, not recruiting
        • Esophagogastric Cancer
        • HER2-Negative
        • Basking Ridge, New Jersey
        • +6 more
        Nov 23, 2022

        Philadelphia-Positive ALL Trial in Suzhou (Olverembatinib combined with chemo)

        Not yet recruiting
        • Philadelphia-Positive ALL
        • Olverembatinib combined with chemotherapy
        • Suzhou, Jiangsu, China
          The First Affiliated Hospital of Soochow University, Jiangsu Ins
        Jul 17, 2022

        Healthy Trial in Bethlehem (Experimental: Within-Subjects Attentional Information)

        Not yet recruiting
        • Healthy
        • Experimental: Within-Subjects Attentional Information
        • Bethlehem, Pennsylvania
          Lehigh University
        Jan 24, 2023

        Acute Lymphoblastic Leukemia (ALL) Trial in Worldwide (Marqibo® (vincristine sulfate liposomes injection))

        Completed
        Has Results
        • Acute Lymphoblastic Leukemia (ALL)
        • Marqibo® (vincristine sulfate liposomes injection)
        • Los Angeles, California
        • +32 more
        Feb 8, 2021

        Acute Lymphocytic Leukemia Trial (Inotuzumab ozogamicin)

        Not yet recruiting
        • Acute Lymphocytic Leukemia
        • Inotuzumab ozogamicin
        • (no location specified)
        Jul 11, 2022

        Integrating Person-based Care in Treatment of Advanced

        Recruiting
        • Advanced Breast Cancer
        • Sharing all key aspects associated with the quality of life in a single digital environment
        • Rome, Italy
          Fondazione Policlinico A. Gemelli - IRCCS
        May 29, 2023